Intelligent Bio Solutions Inc. (INBS) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Analysten schätzen Gewinn pro Aktie (EPS) von $-36.70 und Umsatz von $0.00B für das nächste Geschäftsjahr.
Gewinn pro Aktie (EPS) Erfolgsbilanz: 2024: tatsächlich $-6.38 vs Schätzung $-36.70 (übertroffen +82.6%). 2025: tatsächlich $-20.00 vs Schätzung $-12.50 (verfehlt -60%). Analysten-Genauigkeit: 0%.
GpA-Schätzungen — INBS
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$6.38
vs Est –$36.70
▲ 475.2% off
2025
Actual –$20.00
vs Est –$12.50
▼ 37.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Umsatzschätzungen — INBS
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.003B
vs Est $0.004B
▼ 35.0% off
2025
Actual $0.003B
vs Est $0.012B
▼ 280.0% off
Revenue Trend
Revenue has been relatively flat. Analysts forecast significant revenue growth ahead.
